Seagen
SGEN
#580
Rank
NZ$76.89 B
Marketcap
NZ$407.59
Share price
-0.07%
Change (1 day)
72.27%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -NZ$1.29 Billion

According to Seagen 's latest financial reports the company's current earnings are NZ$2.30 Billion. In 2022 the company made an earning of -NZ$1.1 Billion, an increase over its 2021 earnings that were of -NZ$1.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$1.29 Billion17.46%
2022 -NZ$1.1 Billion-10.13%
2021 -NZ$1.22 Billion-214.28%
2020 NZ$1.06 B-370.63%
2019 -NZ$0.4 Billion-15.17%
2018 -NZ$0.47 Billion32.79%
2017 -NZ$0.35 Billion37.19%
2016 -NZ$0.26 Billion18%
2015 -NZ$0.22 Billion56.34%
2014 -NZ$0.14 Billion23.07%
2013 -NZ$0.12 Billion
2011 -NZ$0.26 Billion111.72%
2010 -NZ$0.13 Billion-19.63%
2009 -NZ$0.16 Billion-7.55%
2008 -NZ$0.17 Billion64.95%
2007 -NZ$99.16 Million38.4%
2006 -NZ$71.65 Million25.36%
2005 -NZ$57.15 Million-14.86%
2004 -NZ$67.13 Million61.92%
2003 -NZ$41.46 Million-7.67%
2002 -NZ$44.9 Million6.76%
2001 -NZ$42.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.30 B-973.67%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$15.50 B-1,200.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$1.80 B-227.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.22 B-1,606.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.05 B-1,097.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.12 Billion-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-NZ$0.12 Billion-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.59 Billion-58.79%๐Ÿ‡บ๐Ÿ‡ธ USA